{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:58:52Z","timestamp":1790135932026,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FIS18\/01138"],"award-info":[{"award-number":["FIS18\/01138"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.rec.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T11:56:16Z","timestamp":1706874976000},"page":"750-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes"],"prefix":"10.1016","volume":"77","author":[{"given":"Sergio","family":"Garc\u00eda-Blas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pernias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika","family":"Gonz\u00e1lez D\u2019Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Fern\u00e1ndez-Cisnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bonanad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2024.01.002_bib0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.01.002_bib0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00392-010-0118-x","article-title":"Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement","volume":"99","author":"Pfister","year":"2010","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0190","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.amjcard.2010.07.051","article-title":"Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation","volume":"106","author":"Kefer","year":"2010","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0195","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1540-8183.2011.00654.x","article-title":"The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation","volume":"24","author":"Spargias","year":"2011","journal-title":"J Interv Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0200","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ejhf.2295","article-title":"Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review","volume":"23","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2024.01.002_bib0205","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0735-1097(03)00311-5","article-title":"Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis","volume":"41","author":"D\u2019Aloia","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/2048872620908033","article-title":"Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure","volume":"9","author":"Mi\u00f1ana","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"10.1016\/j.rec.2024.01.002_bib0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2011.02.001","article-title":"Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure","volume":"159","author":"N\u00fa\u00f1ez","year":"2012","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0220","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/2048872616649757","article-title":"Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure","volume":"6","author":"N\u00fa\u00f1ez","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"10.1016\/j.rec.2024.01.002_bib0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.recesp.2021.01.023","article-title":"Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure","volume":"75","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0230","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jchf.2016.06.007","article-title":"Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study","volume":"4","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rec.2024.01.002_bib0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjmed.2019.07.041","article-title":"CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction","volume":"133","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Am J Med."},{"key":"10.1016\/j.rec.2024.01.002_bib0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijcard.2007.05.039","article-title":"Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement","volume":"128","author":"Antonini-Canterin","year":"2008","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0245","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jcin.2013.02.006","article-title":"Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation","volume":"6","author":"Husser","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.01.002_bib0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.recesp.2016.07.027","article-title":"Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE","volume":"70","author":"Husser","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjcard.2017.11.020","article-title":"Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation","volume":"121","author":"Rheude","year":"2018","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0260","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.athoracsur.2018.03.002","article-title":"The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1\u2014Background, Design Considerations, and Model Development","volume":"105","author":"Shahian","year":"2018","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.rec.2024.01.002_bib0265","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"Nashef","year":"2012","journal-title":"EuroSCORE II. Eur J Cardiothorac Surg"},{"key":"10.1016\/j.rec.2024.01.002_bib0270","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"10.1016\/j.rec.2024.01.002_bib0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ."},{"key":"10.1016\/j.rec.2024.01.002_bib0280","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0285","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jacc.2012.03.075","article-title":"Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis","volume":"60","author":"Reynolds","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J."},{"key":"10.1016\/j.rec.2024.01.002_bib0295","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCOUTCOMES.113.000354","article-title":"How to Define a Poor Outcome After Transcatheter Aortic Valve Replacement","volume":"6","author":"Arnold","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.rec.2024.01.002_bib0300","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2016.07.762","article-title":"Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement","volume":"68","author":"Arnold","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0305","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehv756","article-title":"TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation","volume":"37","author":"Puri","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.01.002_bib0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcmg.2018.03.018","article-title":"Development of a Risk Score Based on Aortic Calcification to Predict 1-Year Mortality After Transcatheter Aortic Valve Replacement","volume":"12","author":"Lantelme","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2024.01.002_bib0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2020.05.043","article-title":"Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation","volume":"130","author":"Lantelme","year":"2020","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0320","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.amjcard.2017.09.007","article-title":"Transcatheter Aortic Valve Implantation Futility Risk Model Development and Validation Among Treated Patients With Aortic Stenosis","volume":"120","author":"Zusman","year":"2017","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0325","doi-asserted-by":"crossref","first-page":"E695","DOI":"10.1002\/ccd.28761","article-title":"Predicting the risk of late futile outcome after transcatheter aortic valve implantation","volume":"96","author":"Zusman","year":"2020","journal-title":"Catheter Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.01.002_bib0330","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10741-013-9402-y","article-title":"Clinical utility of antigen carbohydrate 125 in heart failure","volume":"19","author":"N\u00fa\u00f1ez","year":"2014","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.rec.2024.01.002_bib0335","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehq142","article-title":"Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure","volume":"31","author":"N\u00fa\u00f1ez","year":"2010","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.01.002_bib0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2020.06.033","article-title":"Impact of Loop Diuretic Use on Outcomes Following Transcatheter Aortic Valve Implantation","volume":"131","author":"Cantey","year":"2020","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.01.002_bib0345","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","article-title":"Staging classification of aortic stenosis based on the extent of cardiac damage","volume":"38","author":"G\u00e9n\u00e9reux","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.01.002_bib0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jacc.2022.05.006","article-title":"Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement","volume":"80","author":"G\u00e9n\u00e9reux","year":"2022","journal-title":"J Am Coll Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:50:24Z","timestamp":1724863824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585724000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1885585724000379"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2024.01.002","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2024.01.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}